Colon cancer: Why immunotherapy isn’t always effective

Anton J. Bilchik, a surgical oncologist and a professor of surgery and the chief of medicine at Saint John’s Cancer Institute in California, told Medical News Today that this new research is timely.

“One of the issues [with immunotherapy] is that we know it works in a subset of patients, but it doesn’t work in everyone; and secondly, the response to immunotherapy is not always durable,” explained Bilchik, who was not involved in the study.

Read the full article on Medical News Today.